Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
[DOI] [PMC free article] [PubMed] [Google Scholar] 99.Egerod KL, Petersen N, Timshel PN, Rekling JC, Wang Y, Liu Q, et al
The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033
$WVE $XBIIts amazing that only 10 days before the US election - GLP-1 drugs - Ozempic & others, have made it into the coverage of @TheEconomist due to the promise to cure Diabetes, Obesity, heart disease, liver, kidney problems & maybe even drug addiction and Alzheimers
This dual approach can lead to improved glycaemic control and meaningful weight reduction , addressing two critical aspects of metabolic health simultaneously
US$ 24.45
US$ 26.86
US$ 20.11
US$ 25.11
US$ 22.37
US$ 20.63
US$ 24.21
US$ 27.58
US$ 24.55
US$ 29.87
